CLINICAL_TRIALS
trial_result
· 2019-08-09
Clinical Trial Update: A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus [Phase 2]
Summary
Phase 2 trial update for XmAb5871 in systemic lupus erythematosus has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xencor, Inc. | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2019-08-09